United States Cushing's Syndrome Treatment Market Expansion Driven by Advancing Drug Pipelines & Early Diagnosis | Key Players: Corcept Therapeutics, Piramal Pharma Solutions, LGM Pharma, Sigma Aldrich, Tocris Bioscience

Global Cushing's syndrome market reached US$ 146.5 million in 2023 and is expected to reach US$ 291.1 million by 2031 growing with a CAGR of 8.96% during the forecast period 2024-2031.

The most recent report published by DataM Intelligence indicates that the "Cushing's Syndrome Market" is likely to accelerate significantly in the next few years. The Cushing's Syndrome Market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The Cushing's Syndrome Market study includes information on market factors such as the market dynamics, drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.

Cushing's Syndrome is a rare endocrine disorder caused by prolonged exposure to high cortisol levels, often resulting from tumors or long-term steroid use. The treatment market is advancing with novel drug therapies, surgical interventions, and diagnostic improvements. In the U.S., the FDA has recently approved new therapeutic options, and clinical trials are underway to expand treatment choices, reflecting growing focus on orphan disease management and improved patient outcomes.

Download Latest Sample of This Strategic Report@ https://www.datamintelligence.com/download-sample/cushings-syndrome-market?ophp

The list of Key Players Profiled in the study includes:- Corcept Therapeutics, Piramal Pharma Solutions, LGM Pharma, Sigma Aldrich, Tocris Bioscience, Tecoland Corporation, Sparrow Pharmaceuticals, Novartis AG, Xeris Biopharma, and Zhejiang Supor Pharmaceuticals Co. Ltd.

United States: Recent Developments in Cushing's Syndrome
📌 In May 2025, Corcept Therapeutics announced that the FDA assigned a PDUFA target action date of December 30, 2025 for relacorilant to treat endogenous hypercortisolism, potentially expanding non-surgical options.

📌 In 2025, real-world studies affirmed that osilodrostat (an 11β-hydroxylase inhibitor) effectively reduces cortisol in patients with endogenous Cushing's syndrome, supporting broader clinical adoption.

📌 In 2025, medical reviews emphasized advances in targeted pharmacologic therapies and adrenal-directed drugs, refining treatment strategies for milder and overt Cushing's cases.

Japan: Recent Developments in Cushing's Syndrome

📌 In 2025, a comprehensive review highlighted the discovery of loss-of-function KDM1A mutations as a driver in diet-dependent Cushing's within bilateral macronodular adrenal hyperplasia (PBMAH).

📌 In 2025, a Japanese clinical study reported that patients diagnosed more recently with adrenal Cushing's present fewer classic syndrome features than in past decades, suggesting a shift in clinical phenotype.

📌 In 2025, a case report described an atypical subclinical Cushing's adenoma exhibiting high DHEA-S and cytochrome b5 expression, prompting reconsideration of diagnostic criteria in Japan.

Market Dynamics:

✅Driver: Rising prevalence of endocrine disorders and improved diagnostic techniques fuel demand for treatment.
✅Restraints: High treatment costs and limited availability of targeted therapies restrict accessibility.
✅Opportunities: Advancements in precision medicine and drug development create new avenues for effective treatment.
✅Challenges: Late diagnosis and lack of awareness among patients delay timely treatment and outcomes.

Segmentation Analysis of the Market:

Global Cushing's Syndrome Market forecast report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market. Cushing's Syndrome Market,

By Type

Exogenous Cushing's Syndrome
Endogenous Cushing's Syndrome

By Treatment

Medications
Surgery
Radiation Therapy
Chemotherapy
Others

By End Users

Hospitals
Specialty Clinics
Others

Research Methodology:

- Primary Research: This method involves collecting new and original data for a specific purpose. Primary research is often conducted through surveys, interviews, focus groups, and observation. It enables researchers to obtain first-hand information directly from the target audience, which is especially useful when researching a new or emerging market.

- Secondary Research: This method involves analyzing and synthesizing existing data from various sources such as industry reports, government publications, academic research, and online databases. Secondary research can provide researchers with valuable insights into industry trends, consumer behavior, and Cushing's Syndrome market size and growth, without the need for extensive data collection.

Most research studies use a combination of both primary and secondary research methods to ensure comprehensive and accurate data analysis. The specific methodology used in a Cushing's Syndrome market research study will depend on various factors such as the research objectives, the target audience, and the available resources.

Request Customized Market Entry Assessment for North America, EU, APAC: https://www.datamintelligence.com/customize/cushings-syndrome-market?ophp

Regional Outlook:

The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)

South America (Brazil, Argentina, Rest of SA)

Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

The analysis objectives of the report are:

- To determine the size of the Global Cushing's Syndrome Market by identifying its sub-segments.

- To research the key players and analyze their growth strategies.

- To assess the size and value of the Global Cushing's Syndrome Market based on key regions.

- To analyze the Global Cushing's Syndrome Market in terms of growth trends, potential, and participation in the overall sector.

- To investigate the Global Cushing's Syndrome Market size (volume and value) from the company, key regions/countries, goods and applications, and background data.

- Primary Global Cushing's Syndrome Market manufacturers to specify, clarify, and analyze the product sales volume, value, and market share, market rivalry landscape, SWOT analysis, and future development plans.

- To investigate market competitive developments such as market expansions, agreements, new product launches, and acquisitions.

Reasons to buy:

- Cushing's Syndrome Market Report segments the market based on economic and non-economic aspects and offers a qualitative and quantitative analysis of the market.

- Market value information is provided for each segment and sub-segment in the Cushing's Syndrome Market study.

- The region and market segment identified in this study are those predicted to expand the fastest and account for the majority of market shar

- The Cushing's Syndrome Market Analysis by Geography emphasizes the product or service's consumption in the area and identifies the market-affecting variables for each region.

- The major players' market rankings, as well as the recent partnerships, service/product launches, business expansions, and acquisitions of the companies profiled, are all included in the competitive landscape.

- Extensive company profiles for the top market players, including business overview, company insights, product benchmarking, and SWOT analysis.

- The industry's present and upcoming market outlook in consideration of recent changes, including growth possibilities and drivers as well as obstacles and restrictions in both developing and emerging regions.

- The Cushing's Syndrome Market offers comprehensive market analysis from a variety of angles using Porter's five forces analysis, as well as market insight using the Value Chain.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=cushings-syndrome-market

The report answers a number of crucial questions, including:

- Which companies dominate the global Cushing's Syndrome market?

- What current trends will influence the market over the next few years?

- What are the market's opportunities, obstacles, and driving forces?

- What predictions for the future can help with strategic decision-making?

- What advantages does market research offer businesses?

Get Corporate Access to Live Cushing's Syndrome Industry Intelligence Database: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.